SavedAdd your journal

Journals / Anadolu Psikiyatri Dergisi / 2020 / Cilt: 21 - Sayı: 2

The effects of methylphenidate on weight, height, and body mass index in Turkish children and adolescents with ADHD

DEHB tanılı Türk çocuk ve ergenlerde metilfenidatın ağırlık, boy ve beden kitle indeksi üzerine etkisi

Serkan TURAN
Aynur PEKCANLAR AKAY
Pages
211–217
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS [SDS]: 0.74±1.43, followup height-SDS [SDS]: -0.67±4.35, t-test p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The pathophysiological mechanisms underlying the effects of psychostimulants (methylphenidate)treatment on growth still remain controversial.
📊
Key Findings & Data:We examined the long term effects of methylphenidate on height, weight and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder (ADHD).Methods: Participants (6-18 years, 330 boys, 103 girls) diagnosed with ADHD who received treatment with methylphenidate for at least 1 year at the Department of Child and Adolescent Psychiatry at Dokuz Eylül University Medical School were included in a retrospective study.
💡
Conclusion & Impact:Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS [SDS]: 0.74±1.43, followup height-SDS [SDS]: -0.67±4.35, t-test p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The pathophysiological mechanisms underlying the effects of psychostimulants (methylphenidate)treatment on growth still remain controversial. We examined the long term effects of methylphenidate on height, weight and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder (ADHD).Methods: Participants (6-18 years, 330 boys, 103 girls) diagnosed with ADHD who received treatment with methylphenidate for at least 1 year at the Department of Child and Adolescent Psychiatry at Dokuz Eylül University Medical School were included in a retrospective study. Weight, height, and BMI z scores were converted to age- and gendercorrected z scores using norms from the Turkish population at baseline and last follow-up. Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS [SDS]: 0.74±1.43, followup height-SDS [SDS]: -0.67±4.35, t-test p

Özet

Amaç: Psikostimülan (metilfenidat) tedavisinin büyüme üzerindeki etkilerinin altında yatan patofizyolojik mekanizmalar hala tartışmalıdır. Dikkat eksikliği hiperaktivite bozukluğu (DEHB) olan Türk çocuklarında ve ergenlerinde metilfenidatın boy, kilo ve beden kitle indeksi (BKİ) üzerindeki uzun dönem etkilerinin araştırılması planlanmıştır. Yöntem: Dokuz Eylül Üniversitesi Tıp Fakültesi Çocuk ve Ergen Psikiyatrisi Anabilim Dalı'nda en az 1 yıl boyunca metilfenidat tedavi edilmiş DEHB’li katılımcılar (6-18 yaş, 330 erkek, 103 kız) geriye dönük taranarak çalışmaya alınmıştır. Tedaviye başlamadan önce ve izleme sürecinde ağırlık, boy ve BKİ değerleri, Türk toplum normları kullanarak yaşa ve cinsiyete göre düzeltilmiş z puanlarına dönüştürülmüştür. Bulgular: Boy ve ağırlık z standart sapma puanlarının (SDS) tedavi ile azaldığı saptandı (başlangıç boy-SDS [SDS]: 0.74±1.43, izlem boy-SDS [SDS]:-0.67±4.35, t-testi p

🔖

Cite This Article

TURAN, S., AKAY, A. P. (2022). The effects of methylphenidate on weight, height, and body mass index in Turkish children and adolescents with ADHD. Anadolu Psikiyatri Dergisi, Cilt: 21 - Sayı: 2, 211–217. https://ajindex.com/articles/437841

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington: APP, 2013
  2. Bolea-Alamañac B, Nutt DJ, Adamou M, Asher-son P, Bazire S, Coghill D, et al., British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2014; 28(3):179-203
  3. Golmirzaei J, Mahboobi H, Yazdanparast M, Mushtaq G,Kamal MA, Hamzeyi EA. Psychopharmacology of attention-deficit hyperactivity disorder: Effects and side effects. Curr Pharm Des 2016; 22(5):590-594
  4. Kaplan G, Newcorn JH. Pharmacotherapy for child and adolescent attention deficit hyperactivity disorder. Pediatr Clin North Am 2011; 58(1):99-120
  5. Spencer TJ, Biederman J, Harding M, O’Donnell D, Faraone SV, Wilens TE. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 1996; 35:1460-1469
  6. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychi-atry 2007; 46:1015-1027
  7. Zhang H, Du M, Zhuang S. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD. Neuropediatrics 2010; 41:55-59
  8. Cortese S, Moreira-Maia CR, St Fleur D, MorcilloPen˜alver C, Rohde LA, Faraone SV. Association between ADHD and obesity: A systematic review and metaanalysis. Am J Psychiatry 2016; 173:34-43
  9. Kim HW, Kim SO, Shon S, Lee JS, Lee HJ, Choi JH. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: A retrospective chart review. J Child Adolesc Psychopharmacol 2014; 24:448-453
  10. Powell SG, Frydenberg M, Thomsen PH. The effects of long-term medication on growth in children and adolescents with ADHD: An observational study of a large cohort of real-life patients. Child Adolesc Psychiatry Ment Health 2015; 28:50
  11. Díez-Suárez A, Vallejo-Valdivielso M, Marín-Méndez JJ, de Castro-Manglano P, Soutullo CA. Weight, height, and body mass index in patients with attention-deficit/hyperactivity disorder treated with methylphenidate. J Child Adolesc Psychopharmacol 2017; 27(8):723-730
  12. Lentferink YE, van de Garde EMW, Knibbe CAJ, van der Vorst MMJ. Psychostimulants: influence on